ZAVZPRET™ How should I use ZAVZPRET?

([zavegepant] nasal spray)

How should I use ZAVZPRET?

•
Use ZAVZPRET exactly how your healthcare provider tells you to use it.
•
See the Instructions for Use for complete information on how to use ZAVZPRET nasal spray.
•
ZAVZPRET is given in the nose (nasal) only.
•
Each ZAVZPRET only sprays 1 time and cannot be reused. Do not test or prime the nasal spray before use.
•
Each dose of ZAVZPRET is provided in an individual pack. Use all of the medicine in 1 pack for a complete dose.
•
The recommended dose is 10 mg given as a single spray in one nostril.
•
Do not use more than 1 spray (10 mg) of ZAVZPRET nasal spray in a 24-hour period.
•
It is not known if it is safe to use more than 8 sprays (doses) of ZAVZPRET in 30 days.
•
Avoid using intranasal decongestants with ZAVZPRET. If you have to use an intranasal decongestant, use it at least 1 hour after using ZAVZPRET.

Find ZAVZPRET™ medical information:

Find ZAVZPRET™ medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ZAVZPRET™ Quick Finder

Medication Guide
Download Consumer Medicine Information

Health Professional Information

How should I use ZAVZPRET?

How should I use ZAVZPRET?

•
Use ZAVZPRET exactly how your healthcare provider tells you to use it.
•
See the Instructions for Use for complete information on how to use ZAVZPRET nasal spray.
•
ZAVZPRET is given in the nose (nasal) only.
•
Each ZAVZPRET only sprays 1 time and cannot be reused. Do not test or prime the nasal spray before use.
•
Each dose of ZAVZPRET is provided in an individual pack. Use all of the medicine in 1 pack for a complete dose.
•
The recommended dose is 10 mg given as a single spray in one nostril.
•
Do not use more than 1 spray (10 mg) of ZAVZPRET nasal spray in a 24-hour period.
•
It is not known if it is safe to use more than 8 sprays (doses) of ZAVZPRET in 30 days.
•
Avoid using intranasal decongestants with ZAVZPRET. If you have to use an intranasal decongestant, use it at least 1 hour after using ZAVZPRET.
Prescribing Information
Download Prescribing Information

Health Professional Information

How should I use ZAVZPRET?

How should I use ZAVZPRET?

•
Use ZAVZPRET exactly how your healthcare provider tells you to use it.
•
See the Instructions for Use for complete information on how to use ZAVZPRET nasal spray.
•
ZAVZPRET is given in the nose (nasal) only.
•
Each ZAVZPRET only sprays 1 time and cannot be reused. Do not test or prime the nasal spray before use.
•
Each dose of ZAVZPRET is provided in an individual pack. Use all of the medicine in 1 pack for a complete dose.
•
The recommended dose is 10 mg given as a single spray in one nostril.
•
Do not use more than 1 spray (10 mg) of ZAVZPRET nasal spray in a 24-hour period.
•
It is not known if it is safe to use more than 8 sprays (doses) of ZAVZPRET in 30 days.
•
Avoid using intranasal decongestants with ZAVZPRET. If you have to use an intranasal decongestant, use it at least 1 hour after using ZAVZPRET.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.